⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IPSC News
Century Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
IPSC
Century Therapeutics Reports First Quarter Financial Results and Business Updates
globenewswire.com
IPSC
Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions
globenewswire.com
IPSC
Methyl Methacrylate Adhesives Market worth $2.46 billion by 2030 - Exclusive Report by MarketsandMarkets™
prnewswire.com
MMM
ITW
IPSC
HUN
PH
Form 8-K
sec.gov
IPSC
Form 8-K
sec.gov
IPSC
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
globenewswire.com
IPSC
Century Therapeutics to Participate in Upcoming Investor Conferences in March
globenewswire.com
IPSC
Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes
globenewswire.com
IPSC
Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
globenewswire.com
IPSC